Rigenerand receives regulatory approval for gene therapy production

Authorisation has enabled Rigenerand to enter into clinic, offer CDMO services and consultancy, and plan to expand cleanroom capacity

picture of

Breaking News

Samsung Biologics plans $2bn 'Super Plant' for biomanufacturing

The company has also said that it is in negotiations with the authorities at Incheon Free Economic Zone to purchase ...

Charles River acquires cellular specialist Cellero

Charles River has acquired Cellero to complement recent acquisition of HemaCare by enhancing the supply of critical ...

MicrofluidX makes key collaboration for microfluidics platform

CPI, MicrofluidX and the Cell and Gene Therapy Catapult have collaborated to develop bioprocessing technology for the ...

Increasing process consistency and data integrity in cell and gene therapies

Gene therapy, recognised as one of the most promising opportunities for the comprehensive and precise treatment of ...

CMIC Group establishes biopharma CDMO in Japan

Single-use facility in Shizuoka, Japan has been established to provide process development and GMP manufacturing of ...

Pfizer and BioNTech announce early positive vaccine update

Collaboration has announced results from German Phase 1/2 COVID-19 vaccine study, including first T-Cell response data

A pivotal time for pharma's global biotechnology industry

In these uncertain times, GEA, the globally active mechanical and plant engineering company, is taking its role in the ...

I Peace develops novel system to mass manufacture clinical-grade iPSCs

The system has been developed in collaboration with FANUC for a modular and scalable production

Spirea raises funds for novel ADC platform

Cambridge spin-out has developed a novel ADC platform that achieves a high and stable drug-to-antibody ratio resulting ...

Optimising gene therapy for now and the future

With multiple gene therapies currently approved for use in the US, dozens in pivotal trials and hundreds more in ...

Medical cannabis made in Italy

Dr Fabio Di Francesco, a compounding pharmacist based in Rome, describes how cannabis is used in various dosage forms ...

New technology in cell and gene therapies to meet patient needs

Angela Myers, Head of Gene Editing and Novel Modalities at Merck, outlines the challenges arising with the increasing ...

ChargePoint and STERIS collaborate on fully validated sterile transfer solution

New collaboration has integrated technologies for sterile transfer of drug substances and drug products during ...

R+D Custom Automation makes deal with SiO2 on coronavirus vials

The agreement accelerates the production of SiO2's patented plastic vials for storing novel coronavirus vaccines and ...